Currently, Ryan Stephen Martins holds the position of Chief Financial Officer of 89bio, Inc.

In his past career he occupied the position of Chief Financial Officer at Revolution Medicines, Inc., VP-Corporate Strategy & Investor Relations at Ultragenyx Pharmaceutical, Inc., Principal at Chiron Corp., Associate for Lehman Brothers, Inc., Senior Biotechnology Analyst at Jefferies LLC, Vice President for Barclays Capital, Inc. and Senior Biotechnology Analyst at FM Partners Holdings LLC.

Ryan Stephen Martins received a graduate degree from Virginia Polytechnic Institute & State University, an undergraduate degree and a graduate degree from the University of Mumbai, an MBA from Haas School of Business and an undergraduate degree from St. Xavier's College.